BioCampus Cologne with its property area of 254.000 square meters will be one of the largest biotechnology parks in Germany. BioCampus Cologne offers Life-Science companies a pre-financed infrastructure, S1 and S2 laboratory facilities ready for occupancy with associated office space and sufficient expansion possibilities. Utilization of the shared facilities, such as the representative conference center on the eleventh floor in one of the buildings on campus, the campus restaurant with catering services and the 24/7 security service, relieve the organizational and financial burden on the companies. Until now, successful companies from the life science sector like Axiogenesis AG, AyoxxA Biosystems GmbH, Bayer HealthCare, DIREVO Industrial Biotechnology GmbH, Lonza Cologne AG, Metabolix GmbH, Nexigen GmbH, Sividon Diagnostic GmbH or A. Nattermann & Cie. GmbH / sanofi aventis profit from BioCampus Cologne’s advantages.
The Cologne Chamber of Commerce and Industry is an institution financed by traders, merchants and private companies; statutory membership and fees enable it to represent the general interests of industry, trade and the service sectors. The CCI contacts government and public authorities, parliaments and courts. A dialogue that is beneficial for both sides. For Startups the CCI offers a huge range of services: support in creating your business model or business plan, advice on how to cope with loan and other support programs, information on alternative ways like venture capital and crowdfunding to finance your business, consulting you in questions of growth. Your startup matters are our business!
NRW.BANK is the development bank for North Rhine-Westphalia. It essentially orients its equity products on the life cycle of the firms. Thus, the regional NRW.BANK.Seed Fund invigorates the early-phase funding in North Rhine Westphalia. Young high-tech firms are supported by funding of up to € 8 million via the NRW.BANK.Venture Fund and digital companies via the NRW.BANK.Kreativwirtschaftsfonds. For businesses with above-average growth prospects and a convincing management team NRW.BANK provides contacts to potential private investors within the win NRW.BANK Business Angels Initiative. In addition, the NRW.BANK.Mittelstandsfonds and the NRW.BANK.Spezialfonds provide equity in the amount of € 1 to 7 million to growth intensive mid-cap companies in special funding and restructuring situations.
The policy of the state government of North Rhine-Westphalia of focusing on biotechnology fosters cooperation between companies, research institutions and the public sector along chains of added value within 16 branches and fields of technology. BIO.NRW, one of the 17 state clusters of industry, centrally catalyzes the ongoing development of the strengths of North Rhine-Westphalian biotechnology. BIO.NRW fosters cooperation between researchers, developers, investors and politicians on the state, national and international level.
Within the framework of the North Rhine-Westphalian cluster policy, the cluster BIO.NRW is being funded by the Ministry for Innovation, Science and Research..